Vivos Therapeutics announces proposed rights offering with exercise price floor of $1.25 per share

Vivos Therapeutics, Inc.

Each right entitles holder to buy one share at greater of $1.25/share or 20% above market on day before record date.
Rights are transferable and intended to be listed on an exchange; 9-month exercise period.
Upon exercise, holder receives a subsequent 9-month right at greater of $1.75/share or 40% above market.
Record date set as 30th day after SEC declares registration statement effective; no assurance of completion.
Conditions include SEC effectiveness, shareholder vote for share increase if needed, and board approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.